Tenaya, With $92m Financing, Aims To Win In Cardiology With Three Platforms

 
• By Leah Samuel

Tenaya is working on three separate approaches (gene therapy, cell therapy and small molecule) to develop new treatments for heart disease.

rows of coins and blurred bokeh for finance and banking concept - Image
Tenaya's three-pronged approach to heart disease led to $92m series B. • Source: Shutterstock

More from Financing

More from Business